KR960022474A - 치환된 1h-이미다졸 - Google Patents

치환된 1h-이미다졸 Download PDF

Info

Publication number
KR960022474A
KR960022474A KR1019950049572A KR19950049572A KR960022474A KR 960022474 A KR960022474 A KR 960022474A KR 1019950049572 A KR1019950049572 A KR 1019950049572A KR 19950049572 A KR19950049572 A KR 19950049572A KR 960022474 A KR960022474 A KR 960022474A
Authority
KR
South Korea
Prior art keywords
imidazole
pharmaceutically acceptable
tetrahydro
substituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019950049572A
Other languages
English (en)
Korean (ko)
Inventor
쟌-피에르 지어르츠
제네비에브 모테
에드몬드 디페르딩
쟌-피에르 헤니챠르트
Original Assignee
지. 카파르트
유씨비 에스. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지. 카파르트, 유씨비 에스. 에이. filed Critical 지. 카파르트
Publication of KR960022474A publication Critical patent/KR960022474A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019950049572A 1994-12-14 1995-12-14 치환된 1h-이미다졸 Ceased KR960022474A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9425211.1 1994-12-14
GBGB9425211.1A GB9425211D0 (en) 1994-12-14 1994-12-14 Substituted 1H-imidazoles

Publications (1)

Publication Number Publication Date
KR960022474A true KR960022474A (ko) 1996-07-18

Family

ID=10765918

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950049572A Ceased KR960022474A (ko) 1994-12-14 1995-12-14 치환된 1h-이미다졸

Country Status (26)

Country Link
US (1) US5658938A (https=)
EP (1) EP0717037A1 (https=)
JP (1) JPH08208622A (https=)
KR (1) KR960022474A (https=)
CN (1) CN1054376C (https=)
AR (1) AR002257A1 (https=)
AU (1) AU693614B2 (https=)
BG (1) BG63043B1 (https=)
BR (1) BR9505815A (https=)
CA (1) CA2165133A1 (https=)
CZ (1) CZ327195A3 (https=)
EE (1) EE9500064A (https=)
FI (1) FI955927L (https=)
GB (1) GB9425211D0 (https=)
HU (1) HUT73980A (https=)
IL (1) IL116325A (https=)
IS (1) IS4311A (https=)
MX (1) MX9505063A (https=)
NO (1) NO305316B1 (https=)
NZ (1) NZ280646A (https=)
PL (1) PL311736A1 (https=)
RO (1) RO113346B1 (https=)
RU (1) RU2156239C2 (https=)
SK (1) SK155095A3 (https=)
TW (1) TW303362B (https=)
ZA (1) ZA9510554B (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
ZA981080B (en) 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
US20030073850A1 (en) * 1998-08-07 2003-04-17 Altenbach Robert J. 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
AU5846901A (en) 2000-05-08 2001-11-20 Orion Corp New polycyclic indanylimidazoles with alpha2 adrenergic activity
TW200306783A (en) * 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
AU2007209382A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of CNS disorders
AU2007312390B2 (en) * 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
JP5167265B2 (ja) * 2006-10-19 2013-03-21 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連受容体に親和性を有するアミノメチル−２−イミダゾール
CA2668454A1 (en) * 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles
WO2008058867A2 (en) * 2006-11-16 2008-05-22 F. Hoffmann-La Roche Ag Substituted 4-imidazoles
ES2364701T3 (es) * 2006-12-13 2011-09-12 F. Hoffmann-La Roche Ag Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas.
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
EP2114906B1 (en) 2007-02-02 2014-08-06 F. Hoffmann-La Roche AG 2-aminooxazolines as taar1 ligands for cns disorders
MX2009008777A (es) * 2007-02-13 2009-08-25 Schering Corp Derivados y analogos de cromano como agonistas de los receptores alfa2c adrenergicos funcionalmente selectivos.
WO2008100480A1 (en) * 2007-02-13 2008-08-21 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
EP2125749A2 (en) * 2007-02-13 2009-12-02 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
AU2008270444A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
CA2694362A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
CA2695071A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of cns disorders
AU2008285795A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
WO2009105504A2 (en) 2008-02-21 2009-08-27 Schering Corporation Functionally selective alpha2c adrenoreceptor agonists
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
RU2513086C2 (ru) * 2008-07-24 2014-04-20 Ф.Хоффманн-Ля Рош Аг Производные 4,5-дигидро-оксазол-2-ила
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
EP2356106A1 (en) 2008-10-07 2011-08-17 Schering Corporation Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
US8802673B2 (en) 2011-03-24 2014-08-12 Hoffmann-La Roche Inc Heterocyclic amine derivatives
US9073911B2 (en) 2011-06-09 2015-07-07 Hoffmann-La Roche Inc. Pyrazole derivatives
US9029370B2 (en) 2011-06-10 2015-05-12 Hoffmann-La Roche Inc. Substituted benzamide derivatives
JP5872069B2 (ja) 2012-01-12 2016-03-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 微量アミン関連受容体（ｔａａｒ）としての複素環誘導体
RS56747B1 (sr) 2012-09-14 2018-03-30 Hoffmann La Roche Pirazol derivati karboksamida kao taar modulatori za upotrebu u lečenju nekoliko poremećaja, kao što su depresija, dijabetes i parkinsonova bolest
WO2014041106A1 (en) 2012-09-17 2014-03-20 F. Hoffmann-La Roche Ag Triazole carboxamide derivatives
WO2015165085A1 (en) 2014-04-30 2015-11-05 F.Hoffmann-La Roche Ag Morpholin-pyridine derivatives
MX2016016488A (es) 2014-08-27 2017-03-30 Hoffmann La Roche Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar).
MX2016016190A (es) 2014-08-27 2017-03-08 Hoffmann La Roche Derivados de pirazino[2,1-a]isoquinolina sustituida para el tratamiento de trastornos del sistema nervioso central.
WO2017157873A1 (en) 2016-03-17 2017-09-21 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
BR112018068688B1 (pt) * 2016-03-17 2023-02-14 Fmc Corporation Processo para converter enantiômero s em sua forma racêmica, composto e uso do mesmo
CN116496261B (zh) * 2023-03-09 2025-06-27 中国人民解放军军事科学院军事医学研究院 4-(1h)-咪唑类衍生物及其医药用途
CN118684628B (zh) * 2024-05-20 2025-06-17 中国人民解放军军事科学院军事医学研究院 取代二氢茚基咪唑类化合物及其制备方法和用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
EP0269599A2 (fr) * 1986-11-04 1988-06-01 U C B, S.A. 1H-Imidazoles substitués
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
EP0717037A1 (fr) * 1994-12-14 1996-06-19 U C B, S.A. 1H-imidazoles substitués ayant une activité alpha 2-agoniste et alpha 1-antagoniste

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048972A (ja) * 1983-08-25 1985-03-16 Dai Ichi Seiyaku Co Ltd テトラヒドロナフタレン誘導体
EP0269599A2 (fr) * 1986-11-04 1988-06-01 U C B, S.A. 1H-Imidazoles substitués
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
JPH04210680A (ja) * 1990-12-01 1992-07-31 Nissan Chem Ind Ltd イミダゾール誘導体および植物生長調節剤
EP0717037A1 (fr) * 1994-12-14 1996-06-19 U C B, S.A. 1H-imidazoles substitués ayant une activité alpha 2-agoniste et alpha 1-antagoniste

Also Published As

Publication number Publication date
HUT73980A (en) 1996-10-28
CA2165133A1 (en) 1996-06-15
FI955927A7 (fi) 1996-06-15
BR9505815A (pt) 1998-01-06
EE9500064A (et) 1996-06-17
EP0717037A1 (fr) 1996-06-19
BG63043B1 (bg) 2001-02-28
CZ327195A3 (en) 1996-07-17
NO955034D0 (no) 1995-12-12
AR002257A1 (es) 1998-03-11
IL116325A0 (en) 1996-03-31
IS4311A (is) 1996-06-15
CN1133837A (zh) 1996-10-23
NZ280646A (en) 1996-08-27
AU693614B2 (en) 1998-07-02
RU2156239C2 (ru) 2000-09-20
MX9505063A (es) 1997-01-31
SK155095A3 (en) 1997-02-05
FI955927A0 (fi) 1995-12-11
PL311736A1 (en) 1996-06-24
JPH08208622A (ja) 1996-08-13
NO305316B1 (no) 1999-05-10
CN1054376C (zh) 2000-07-12
BG100208A (bg) 1996-07-31
TW303362B (https=) 1997-04-21
RO113346B1 (ro) 1998-06-30
IL116325A (en) 1999-10-28
HU9503549D0 (en) 1996-02-28
ZA9510554B (en) 1996-06-13
FI955927L (fi) 1996-06-15
GB9425211D0 (en) 1995-02-15
US5658938A (en) 1997-08-19
NO955034L (no) 1996-06-17
AU4036895A (en) 1996-06-20

Similar Documents

Publication Publication Date Title
KR960022474A (ko) 치환된 1h-이미다졸
RU95120582A (ru) Замещенные 4-(1,2,3,4-тетрагидро-1-нафталинил)-1н-имидазолы и 4-(2,3-дигидро-1н-инден-1-ил)-1н-имидазолы, способы их получения и фармацевтическая композиция на их основе
KR920021512A (ko) 신규의 디알킬렌피페리디노 화합물 및 이의 거울상 이성질체 이의 제조방법 및 이를 함유하는 약제학적 조성물
ATE17121T1 (de) Substituierte imidazolderivate und deren herstellung und anwendung.
BR9915895A (pt) Composto, uso do mesmo, processo para prepará-lo, método para o tratamento de um mamìfero, incluindo o homem, de condições resultantes de nìveis de circulação elevados de apob-100, e, composição farmacêutica
MA26696A1 (fr) Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DE69324140D1 (de) Kondensierte imidazol- und triazolderivate als 5-hta rezeptoragonisten
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
KR940014384A (ko) 항바이러스제로서의 페녹시- 및 페녹시알킬-피페리딘
ATE10192T1 (de) Substituierte imidazol-derivate, deren herstellung und verwendung.
CA2221110A1 (en) Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
GB1399015A (en) Fluoroalkylated phenylethylamine derivatives
PT83043B (pt) Processo para a preparacao de 3-imidazolilmetil-tetra-hidro-carbazolonas
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
KR880006205A (ko) 치환된 1h-이미다졸
KR880012566A (ko) 피페리진 유도체
KR910006309A (ko) 인지질 및 인지질 유도체를 유효 성분으로 하는 항비루스성 약제
ATE40997T1 (de) 1,5-benzothiazepin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen sowie ihre verwendung.
US4404387A (en) Aminoalkyl-substituted imidazoles
KR910007912A (ko) 피리돈의 신규 유도체, 이들의 제조 방법, 신규 중간체, 약제로서 이들의 용도 및 이들을 함유한 조성물
ATE243202T1 (de) Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
KR950704297A (ko) 항헬리코박터 활성을 갖는 4-퀴놀리닐 유도체(4-quinolinyl derivatives with anti helicobacter activity)
KR900011759A (ko) 사이클로 헥산아세트 아미드 유도체
US5681863A (en) Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
DE69815380D1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19951214

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20001206

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19951214

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20021125

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20030221

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20021125

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I